Euroopa farmakopöa asjus

Signe Leito Saatja: [email protected] Saatmisaeg: neljapäev, 9. aprill 2026 18:10 Adressaat: Signe Leito Teema: Chloroquine sulfate (545): proposed suppression from the European Pharmacopoeia (Ph. Eur.): EDQM-2026-01790-mail Järeltegevuse lipp: Järeltegevus Olekulipp: Lipuga märgitud Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada. Please make sure to include in any reply our mail reference: EDQM-2026-01790-mail **************************************************************************** For the attention of NPAs Copy: Presidium Dear Colleagues, Please find below the link to a survey being carried out concerning the proposed suppression of the monograph on Chloroquine sulfate (545) from the European Pharmacopoeia. In order to have access to the survey, please copy and paste the following link into your Internet browser: https://survey.edqm.eu/index.php?r=survey/index&sid=627249&newtest=Y&lang=en Deadline for replies: 3 May 2026 Thank you. Best regards, On behalf of Mrs Aurelie Barth Andreea Mocoi Administrative Support Assistant European Pharmacopoeia Department European Directorate for the Quality of Medicines & HealthCare Council of Europe - Conseil de l'Europe Tel.: +33 (0)3 90 21 64 63 / Fax: +33 (0)3 88 41 27 71 https://www.edqm.eu / https://www.edqm.eu/store Stay connected with the EDQM To reach us, we invite you to contact us electronically. You can also contact us via HelpDesk https://www.edqm.eu / https://store.edqm.eu Stay connected with the EDQM **************************************************************************** Please make sure to include in any reply our mail reference: EDQM-2026-01790-mail 1